ANI Pharmaceuticals is building a leading Rare Disease company focused on Serving Patients, Improving Lives

RECENT NEWS

ANI Pharmaceuticals Announces Offer to Acquire Egetis Therapeutics, Expanding the Scope and Scale of Its Rare Disease Business

2026-11-05

READ MORE >

ANI Pharmaceuticals to Present at Upcoming November Investor Conferences

2026-11-03

READ MORE >

NASDAQ - ANIP

$71.65

0 (0%)

Pricing delayed by 20 minutes
Last updated 2026-11-04 16:15:00